Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 26 May 2009, doi:10.1136/bmj.b2135
Cite this as: BMJ 2009;338:b2135
Annette Tuffs
1 Heidelberg
| The first 150 words of the full text of this article appear below. |
An independent expert committee has concluded that two doctors from Freiburg University Hospital, Lothar Heinrich and Andreas Schmid, were extensively involved in providing performance enhancing drugs to professional cyclists for profit. The committees report was presented to a press conference earlier this month by Hans-Jochen Schiewer, the rector of Freiburg University, Wolfgang Holzgreve, the director of Freiburg University Hospital, and Hans Joachim Schäfer, the head of the committee.
It found that the two doctors administered performance enhancing drugs, deceived the hospital and the public, and acted against Germanys law on transfusion.
The investigation followed revelations in 2007 in the German weekly magazine Der Spiegel about the practices of two Freiburg doctors (BMJ 2007;334:1184-5, doi:10.1136/bmj.39234.707766.DB).
Within four weeks of the articles publication Dr Heinrich and Professor Schmid, both sports medicine specialists, admitted that they had given the blood cell stimulating hormone erythropoietin to the cycling team of the
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses